295 related articles for article (PubMed ID: 21664213)
1. Increased expression of cytochrome P450 2E1 in nonalcoholic fatty liver disease: mechanisms and pathophysiological role.
Aubert J; Begriche K; Knockaert L; Robin MA; Fromenty B
Clin Res Hepatol Gastroenterol; 2011 Oct; 35(10):630-7. PubMed ID: 21664213
[TBL] [Abstract][Full Text] [Related]
2. Hepatic cytochrome P450 2E1 activity in nonalcoholic fatty liver disease.
Prompila N; Wittayalertpanya S; Komolmit P
J Med Assoc Thai; 2008 May; 91(5):733-8. PubMed ID: 18672640
[TBL] [Abstract][Full Text] [Related]
3. Hepatic cytochrome P450 2E1 is increased in patients with nonalcoholic steatohepatitis.
Weltman MD; Farrell GC; Hall P; Ingelman-Sundberg M; Liddle C
Hepatology; 1998 Jan; 27(1):128-33. PubMed ID: 9425928
[TBL] [Abstract][Full Text] [Related]
4. Expression and activity of the cytochrome P450 2E1 in patients with nonalcoholic steatosis and steatohepatitis.
Chtioui H; Semela D; Ledermann M; Zimmermann A; Dufour JF
Liver Int; 2007 Aug; 27(6):764-71. PubMed ID: 17617119
[TBL] [Abstract][Full Text] [Related]
5. Redox balance in the pathogenesis of nonalcoholic fatty liver disease: mechanisms and therapeutic opportunities.
Gambino R; Musso G; Cassader M
Antioxid Redox Signal; 2011 Sep; 15(5):1325-65. PubMed ID: 20969475
[TBL] [Abstract][Full Text] [Related]
6. From the metabolic syndrome to NAFLD or vice versa?
Vanni E; Bugianesi E; Kotronen A; De Minicis S; Yki-Järvinen H; Svegliati-Baroni G
Dig Liver Dis; 2010 May; 42(5):320-30. PubMed ID: 20207596
[TBL] [Abstract][Full Text] [Related]
7. Mitochondrial adaptations and dysfunctions in nonalcoholic fatty liver disease.
Begriche K; Massart J; Robin MA; Bonnet F; Fromenty B
Hepatology; 2013 Oct; 58(4):1497-507. PubMed ID: 23299992
[TBL] [Abstract][Full Text] [Related]
8. Fatty liver: role of inflammation and fatty acid nutrition.
Byrne CD
Prostaglandins Leukot Essent Fatty Acids; 2010; 82(4-6):265-71. PubMed ID: 20189787
[TBL] [Abstract][Full Text] [Related]
9. CYP2E1 activity before and after weight loss in morbidly obese subjects with nonalcoholic fatty liver disease.
Emery MG; Fisher JM; Chien JY; Kharasch ED; Dellinger EP; Kowdley KV; Thummel KE
Hepatology; 2003 Aug; 38(2):428-35. PubMed ID: 12883487
[TBL] [Abstract][Full Text] [Related]
10. Study of cytochrome P450 2E1 and its allele variants in liver injury of nondiabetic, nonalcoholic steatohepatitis obese women.
Varela NM; Quiñones LA; Orellana M; Poniachik J; Csendes A; Smok G; Rodrigo R; Cáceres DD; Videla LA
Biol Res; 2008; 41(1):81-92. PubMed ID: 18769766
[TBL] [Abstract][Full Text] [Related]
11. Role of fatty acids in the pathogenesis of obesity and fatty liver: impact of bariatric surgery.
Verna EC; Berk PD
Semin Liver Dis; 2008 Nov; 28(4):407-26. PubMed ID: 18956297
[TBL] [Abstract][Full Text] [Related]
12. Increased hepatic and circulating interleukin-6 levels in human nonalcoholic steatohepatitis.
Wieckowska A; Papouchado BG; Li Z; Lopez R; Zein NN; Feldstein AE
Am J Gastroenterol; 2008 Jun; 103(6):1372-9. PubMed ID: 18510618
[TBL] [Abstract][Full Text] [Related]
13. Role of Mitochondrial Cytochrome P450 2E1 in Healthy and Diseased Liver.
Massart J; Begriche K; Hartman JH; Fromenty B
Cells; 2022 Jan; 11(2):. PubMed ID: 35053404
[TBL] [Abstract][Full Text] [Related]
14. Hepatic cytochrome P450 2E1 activity in nondiabetic patients with nonalcoholic steatohepatitis.
Chalasani N; Gorski JC; Asghar MS; Asghar A; Foresman B; Hall SD; Crabb DW
Hepatology; 2003 Mar; 37(3):544-50. PubMed ID: 12601351
[TBL] [Abstract][Full Text] [Related]
15. Hepatic lipid peroxidation and cytochrome P-450 2E1 in pediatric nonalcoholic fatty liver disease and its subtypes.
Bell LN; Molleston JP; Morton MJ; Klipsch A; Saxena R; Vuppalanchi R; Chalasani N
J Clin Gastroenterol; 2011 Oct; 45(9):800-7. PubMed ID: 21602702
[TBL] [Abstract][Full Text] [Related]
16. CYP2E1 and oxidant stress in alcoholic and non-alcoholic fatty liver disease.
Leung TM; Nieto N
J Hepatol; 2013 Feb; 58(2):395-8. PubMed ID: 22940046
[TBL] [Abstract][Full Text] [Related]
17. Molecular mechanisms of steatosis in nonalcoholic fatty liver disease.
Pettinelli P; Obregón AM; Videla LA
Nutr Hosp; 2011; 26(3):441-50. PubMed ID: 21892559
[TBL] [Abstract][Full Text] [Related]
18. Expression of genes encoding mitochondrial proteins can distinguish nonalcoholic steatosis from steatohepatitis.
Bragoszewski P; Habior A; Walewska-Zielecka B; Ostrowski J
Acta Biochim Pol; 2007; 54(2):341-8. PubMed ID: 17502923
[TBL] [Abstract][Full Text] [Related]
19. Relevance of CYP2E1 to non-alcoholic fatty liver disease.
Daly AK
Subcell Biochem; 2013; 67():165-75. PubMed ID: 23400921
[TBL] [Abstract][Full Text] [Related]
20. [Nonalcoholic steatohepatitis: pathogenesis and treatment].
Park SH
Korean J Hepatol; 2008 Mar; 14(1):12-27. PubMed ID: 18367854
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]